Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Inventory: 2021-2025

Historic Change in Inventory for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Sep 2025 value amounting to -$6.8 million.

  • Kiniksa Pharmaceuticals International's Change in Inventory fell 9.83% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 310.59%. This contributed to the annual value of -$4.8 million for FY2024, which is 149.96% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Change in Inventory stood at -$6.8 million for Q3 2025, which was down 125.98% from $26.1 million recorded in Q2 2025.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Change in Inventory peaked at $26.1 million during Q2 2025, and registered a low of -$6.8 million during Q3 2025.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Change in Inventory had a median value of $533,000 in 2023 and averaged $1.8 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 583.23% in 2022, then surged by 1,322.14% in 2024.
  • Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Change in Inventory stood at -$1.9 million in 2021, then spiked by 461.37% to $7.0 million in 2022, then dropped by 20.62% to $5.5 million in 2023, then plummeted by 141.81% to -$2.3 million in 2024, then fell by 9.83% to -$6.8 million in 2025.
  • Its Change in Inventory was -$6.8 million in Q3 2025, compared to $26.1 million in Q2 2025 and -$4.3 million in Q1 2025.